Your browser doesn't support javascript.
loading
Building a network of TP53 and IGHV testing reference centers across Spain: the Red53 initiative.
Bosch, Francesc; Navarro, Blanca; Crespo, Marta; Alcoceba, Miguel; Sánchez, Julio Bravo; Tazón, Barbara; Serrano, Alicia; Álvarez, María García; Serrano, Lydia González; Alonso-Torres, Pablo; Villanueva, Miguel; Loriente, Cristina; Abrisqueta, Pau; Peiró, Manel; García-Marco, José Antonio; González, Marcos; Terol, María José.
Affiliation
  • Bosch F; Servei d'Hematologia, Vall d'Hebron Hospital Universitari, Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain. fbosch@vhio.net.
  • Navarro B; Department of Hematology, University Clinic Hospital of Valencia, INCLIVA Institute, Valencia, Spain.
  • Crespo M; Servei d'Hematologia, Vall d'Hebron Hospital Universitari, Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
  • Alcoceba M; Department of Hematology, University Hospital of Salamanca (HUS/IBSAL), CIBERONC and Center for Cancer Research-IBMCC (USAL-CSIC), Salamanca, Spain.
  • Sánchez JB; Department of Hematology, Hospital Universitario Puerta de Hierro-Majadahonda, IDIPHIM-Segovia de Arana, Madrid, Spain.
  • Tazón B; Servei d'Hematologia, Vall d'Hebron Hospital Universitari, Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
  • Serrano A; Department of Hematology, University Clinic Hospital of Valencia, INCLIVA Institute, Valencia, Spain.
  • Álvarez MG; Department of Hematology, University Hospital of Salamanca (HUS/IBSAL), CIBERONC and Center for Cancer Research-IBMCC (USAL-CSIC), Salamanca, Spain.
  • Serrano LG; Department of Hematology, Hospital Universitario Puerta de Hierro-Majadahonda, IDIPHIM-Segovia de Arana, Madrid, Spain.
  • Alonso-Torres P; Janssen Pharmaceutical Companies of Johnson & Johnson, Madrid, Spain.
  • Villanueva M; Janssen Pharmaceutical Companies of Johnson & Johnson, Madrid, Spain.
  • Loriente C; Janssen Pharmaceutical Companies of Johnson & Johnson, Madrid, Spain.
  • Abrisqueta P; Servei d'Hematologia, Vall d'Hebron Hospital Universitari, Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
  • Peiró M; ESADE Business School, Institute for Healthcare Management, Universitat Ramon Llull, Barcelona, Spain.
  • García-Marco JA; Department of Hematology, Hospital Universitario Puerta de Hierro-Majadahonda, IDIPHIM-Segovia de Arana, Madrid, Spain.
  • González M; Department of Hematology, University Hospital of Salamanca (HUS/IBSAL), CIBERONC and Center for Cancer Research-IBMCC (USAL-CSIC), Salamanca, Spain.
  • Terol MJ; Department of Hematology, University Clinic Hospital of Valencia, INCLIVA Institute, Valencia, Spain.
Ann Hematol ; 100(3): 825-830, 2021 Mar.
Article in En | MEDLINE | ID: mdl-33409623
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Referral and Consultation / DNA Mutational Analysis / Leukemia, Lymphocytic, Chronic, B-Cell / Tumor Suppressor Protein p53 / Immunoglobulin Heavy Chains / Clinical Laboratory Services Type of study: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Sysrev_observational_studies Aspects: Implementation_research Limits: Humans Country/Region as subject: Europa Language: En Journal: Ann Hematol Journal subject: HEMATOLOGIA Year: 2021 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Referral and Consultation / DNA Mutational Analysis / Leukemia, Lymphocytic, Chronic, B-Cell / Tumor Suppressor Protein p53 / Immunoglobulin Heavy Chains / Clinical Laboratory Services Type of study: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Sysrev_observational_studies Aspects: Implementation_research Limits: Humans Country/Region as subject: Europa Language: En Journal: Ann Hematol Journal subject: HEMATOLOGIA Year: 2021 Document type: Article Affiliation country: Country of publication: